Trial NCT00636441

View at ClinicalTrials.gov 
Org. Study IDs: Pro00001345
Secondary IDs: BC060228-W81XWH-07-1-0394 W81XWH-07-1-0394

Last trial update was posted on 2015-12-11

MeSH Interventions

Cyclophosphamide Docetaxel Doxorubicin Liposomal doxorubicin

MeSH Conditions

Breast Neoplasms

Other Conditions

Early-Stage Breast Cancer

Stopping Reasons

Study terminated due to reproducibility issues with genomics prediction model

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID